510(k) Report

510(k) · Cleared

Cleared

Mucograft

K012423510(k) TraditionalCleared Jan 24, 2003543-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ed. Geistlich Soehne AG Fuer Chemische Industrie · NPL Barrier, Animal Source, Intraoral

Cleared on Jan 24, 2003 after a 543-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 17 later devices descend from it.

Decided
Jan 24, 2003
Review
543 days
Class
Class II
Product code
NPL
Recalls
None
Predicates
0

17 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2008: 1 descendant cleared2014: 1 descendant cleared2006: 1 descendant cleared2022: 2 descendants cleared2021: 1 descendant cleared2020: 1 descendant cleared2017: 1 descendant cleared2019: 1 descendant cleared2025: 4 descendants cleared2023: 1 descendant cleared2024: 1 descendant cleared2026: 1 descendant cleared200020052010201520202025
  1. This deviceK012423 MucograftEd. Geistlich Soehne AG Fuer Chemische Industrie · 2003
  2. Descendant · cites it directly · 16 of its ownK061244 MucograftEd. Geistlich Soehne AG Fuer Chemische Industrie · 2006
  3. Descendant · cites it directly · 15 of its ownK073711 Mucograft Collagen MatrixEd. Geistlich Soehne AG Fuer Chemische Industrie · 2008
  4. Descendant · cites it directly · 13 of its ownK102531 MucograftEd. Geistlich Soehne AG Fur Chemische Industrie · 2010
  5. Descendant · cites it directly · 10 of its ownK140518 Geistlich Mucograft: 15 X 20 MM, 20 X 30 MM, 8 MM DiameterGeistlich Pharma AG · 2014
  6. Descendant · 2 generations on · 9 of its ownK192042 Geistlich Bio-Gide, Geistlich Bio-Gide Shape, Geistlich Bio-Gide…Geistlich Pharma AG · 2019

Showing 5 of 17 descendants. See all descendants

Descendants cleared per year

2006: 12008: 12010: 12014: 12017: 12019: 12020: 12021: 12022: 22023: 12024: 12025: 42026: 1
2006high 4 (2025) · low 0 (2007)2026

Most influential descendants

Showing 5 of 17 · See all
  • K061244MucograftEd. Geistlich Soehne AG Fuer Chemische Industrie · 2006 · cites it directly16descendants
  • K073711Mucograft Collagen MatrixEd. Geistlich Soehne AG Fuer Chemische Industrie · 2008 · cites it directly15descendants
  • K102531MucograftEd. Geistlich Soehne AG Fur Chemische Industrie · 2010 · cites it directly13descendants
  • K140518Geistlich Mucograft: 15 X 20 MM, 20 X 30 MM, 8 MM DiameterGeistlich Pharma AG · 2014 · cites it directly10descendants
  • K192042Geistlich Bio-Gide, Geistlich Bio-Gide Shape, Geistlich Bio-Gide Compressed, Geistlich…Geistlich Pharma AG · 2019 · 2 generations on9descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K012423MucograftEd. Geistlich Soehne AG Fuer Chemische Industrie2003—
+1K061244MucograftEd. Geistlich Soehne AG Fuer Chemische Industrie2006—
+1K073711Mucograft Collagen MatrixEd. Geistlich Soehne AG Fuer Chemische Industrie2008—
+1K102531MucograftEd. Geistlich Soehne AG Fur Chemische Industrie2010—
+1K140518Geistlich Mucograft: 15 X 20 MM, 20 X 30 MM, 8 MM DiameterGeistlich Pharma AG2014—
+2K192042Geistlich Bio-Gide, Geistlich Bio-Gide Shape, Geistlich Bio-Gide Compressed…Geistlich Pharma AG2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200810
201010
201410
201710
201910
202010
202110
202220
202310
202410
202540
202610
FIG. 1 — Lineage of K012423, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NPL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NPL device

  1. #1 K212463 Geistlich Bio-Gide, Geistlich Bio-Gide Shape…score 14.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (17)

See all 17

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K061244MucograftEd. Geistlich Soehne AG Fuer Chemische Industrie200616
K073711Mucograft Collagen MatrixEd. Geistlich Soehne AG Fuer Chemische Industrie200815
K102531MucograftEd. Geistlich Soehne AG Fur Chemische Industrie201013
K140518Geistlich Mucograft: 15 X 20 MM, 20 X 30 MM, 8 MM DiameterGeistlich Pharma AG201410

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K061244 (Ed. Geistlich Soehne AG Fuer Chemische Industrie, 2006) has gone furthest, with 16 descendants of its own.

How does its category compare?

All NPL devices

NPL Barrier, Animal Source, Intraoral: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NPL

5in 2025

2007: 12008: 42009: 32010: 22011: 42013: 22014: 52015: 12016: 32017: 32018: 12019: 12020: 22021: 22022: 32023: 22024: 32025: 5
2007high 5 (2014) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NPL

132in 2025

2008: 172 days median2009: 193 days median2011: 286 days median2014: 140 days median2016: 184 days median2017: 200 days median2022: 290 days median2024: 263 days median2025: 132 days median
2007high 290 (2022) · low 132 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NPL

6in 2019

2012: 32019: 6
2007high 6 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NPL

39in 2025

2012: 32013: 22014: 32015: 52016: 92017: 182018: 142019: 222020: 82021: 112022: 192023: 52024: 202025: 39
2007high 39 (2025) · low 0 (2007)2025

MAUDE reports naming product code NPL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
2008417200
2009319300
20102—00
2011428600
20120—33
20132—02
2014514003
20151—05
2016318409
20173200018
20181—014
20191—622
20202—08
20212—011
20223290019
20232—05
20243263020
20255132039
20260—0—

What is it indicated for?

INDICATIONS:

MUCOGRAFT® is indicated for:

- simultaneous use of GBR-membrane (MUCOGRAFTB) and implants;

- augmentation around implants placed in immediate extraction sockets;

- augmentation around implants placed in delayed extraction sockets;

- localized ridge augmentation for later implantation;

- alveolar ridge reconstruction for prosthetic treatment;

- filling of bone defects after root resection, cystectomy, removal of retained teeth;

- guided bone regeneration in dehiscence defects.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012423: Mucograft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K012423

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026